The Immunity Job

Courtesy of Jessica BonameLike the impossibly well-funded thieves from a good heist film, viruses pull immune-escape strategies from a deep bag of tricks. Murine γ-herpesvirus-68 (MHV-68) fine-tunes its attack on MHC class I molecules by degrading components of the complex that loads them with peptides.1"There's the primary targeting of the class I heavy chain," says Jessica Boname, in Philip Stevenson's lab at the University of Cambridge, who showed previously that MHV-68's MK3 protein dir

Written byA Nicola Schweitzer
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of Jessica Boname

Like the impossibly well-funded thieves from a good heist film, viruses pull immune-escape strategies from a deep bag of tricks. Murine γ-herpesvirus-68 (MHV-68) fine-tunes its attack on MHC class I molecules by degrading components of the complex that loads them with peptides.1

"There's the primary targeting of the class I heavy chain," says Jessica Boname, in Philip Stevenson's lab at the University of Cambridge, who showed previously that MHV-68's MK3 protein directs proteasomal degradation of MHC class I molecules. "But, there's also a direct effect," says Boname. MK3 targets components of the TAP complex, which normally loads peptides onto the MHCs.

MHC class I molecule assembly and cell-surface expression rely on peptide availability. By sabotaging peptide loading, MK3 undermines the MHC molecule indirectly as well as directly. This helps explain how MHV-68 can activate and replicate in B cells without being presented to CD8 T cells ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies